Oncology collaboration established to accelerate translational cancer research Read more Blood test picks out cancers likely to benefit from targeted drugs Read more here Shorter radiotherapy course reduces risk of bladder cancer returning Read morePreviousNext Highlights Research is key to future treatment Our six research themes and two cross-cutting themes bring together a critical mass of internationally renowned clinicians, scientists and allied health professionals, allowing us to ensure that novel diagnostics and physical and systemic therapies are rapidly available to all cancer patients. Patient and public involvement and engagement Involving patients and the public with our research ensures that we focus on the issues that matter most to those affected by cancer. Find out more Latest news First Covid jab provides protection A single dose of a Covid-19 vaccine triggers an immune response in around 70 per cent of myeloma blood cancer patients – suggesting that it does provide protection against the virus. Find out more Resistance-busting drug enters clinical trial A drug discovered at the Institute of Cancer Research that could counteract drug resistance in various cancers has entered a phase I clinical trial at The Royal Marsden NHS Foundation Trust. Find out more Early promise in treating aggressive brain cancers Early results from a Phase I trial suggest immunotherapy combined with an experimental cancer drug could offer a new way of treating some patients with aggressive brain cancers. Find out more More information Upcoming events Patient and public involvement and engagement BRC training hub Magazine articles
